Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ion Beam Applications SA

Latest From Shionogi Inc.

Medicines Patent Pool Expands From HIV To Hepatitis C & TB, With 100 Projects On The Go

Drugs for hepatitis C and tuberculosis are now being licensed for generic production under the aegis of the Medicines Patent Pool, which says it now has 15 generic manufacturing partners working on more than 100 projects across the hepatitis C, TB and HIV areas.

Emerging Markets Intellectual Property

Janssen Strives For Simplicity In HIV R&D, While Hunting For A Cure

HIV may be effectively treated and managed with available therapies, but there is still great unmet need for a functional cure and better prevention to stop the epidemic.

Clinical Trials Infectious Diseases

10 Approvals To Watch For In Early 2017

Dupixent, Austedo, brigatinib and Olumiant are among a raft of new drug approvals expected in the first four months of the year. Here, with help from Informa Pharma's Biomedtracker, we take a look at 10 of the more interesting products looking close to reaching the market, some for the second time of asking.

Approvals Commercial

Purdue Is Open For Business Deals And Shopping On Multiple Fronts

The private pain specialist is interested in business development opportunities in its core therapeutic space and adjacencies, but also looking at other ‘innovative’ technologies and partnerships with ex-US drug manufacturers, CEO Timney said during an interview.

Business Strategies Deals
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Medical Devices
    • Laser
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Belgium
  • Parent & Subsidiaries
  • Ion Beam Applications SA
  • Senior Management
  • Yves Jongen, Pres.
    Sybille van den Hove, Mgr., Mktg. & Sales
    Emile Conard, Mgr., R&D
  • Contact Info
  • Ion Beam Applications SA
    Phone: (32) 10 47 5811
    Chemin du Cyclotron, 2
    1348 Louvain Neuve,